Longreach Is Said to Weigh Sale of HK Medical Device Firm Quasar
- Sale has drawn preliminary interest from prospective investors
- A transaction could value the business at up to $400 million
This article is for subscribers only.
Asian buyout firm Longreach Group is considering a sale of its majority stake in medical device maker Quasar amid interest from potential investors, according to people familiar with the matter.
Longreach is in talks with financial advisers as it prepares a potential divestment of Hong Kong-based Quasar, the people said, asking not to be identified because the matter is private. A transaction could value the business at around $300 million to $400 million, the people said.